Unknown

Dataset Information

0

One-Component Supramolecular Filament Hydrogels as Theranostic Label-Free Magnetic Resonance Imaging Agents.


ABSTRACT: Gadolinium (Gd)-based compounds and materials are the most commonly used magnetic resonance imaging (MRI) contrast agents in the clinic; however, safety concerns associated with their toxicities in the free ionic form have promoted the development of new generations of metal-free contrast agents. Here we report a supramolecular strategy to convert an FDA-approved anticancer drug, Pemetrexed (Pem), to a molecular hydrogelator with inherent chemical exchange saturation transfer (CEST) MRI signals. The rationally designed drug-peptide conjugate can spontaneously associate into filamentous assemblies under physiological conditions and consequently form theranostic supramolecular hydrogels for injectable delivery. We demonstrated that the local delivery and distribution of Pem-peptide nanofiber hydrogels can be directly assessed using CEST MRI in a mouse glioma model. Our work lays out the foundation for the development of drug-constructed theranostic supramolecular materials with an inherent CEST MRI signal that enables noninvasive monitoring of their in vivo distribution and drug release.

SUBMITTER: Lock LL 

PROVIDER: S-EPMC5773287 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

One-Component Supramolecular Filament Hydrogels as Theranostic Label-Free Magnetic Resonance Imaging Agents.

Lock Lye Lin LL   Li Yuguo Y   Mao Xinpei X   Chen Hanwei H   Staedtke Verena V   Bai Renyuan R   Ma Wang W   Lin Ran R   Li Yi Y   Liu Guanshu G   Cui Honggang H  

ACS nano 20170111 1


Gadolinium (Gd)-based compounds and materials are the most commonly used magnetic resonance imaging (MRI) contrast agents in the clinic; however, safety concerns associated with their toxicities in the free ionic form have promoted the development of new generations of metal-free contrast agents. Here we report a supramolecular strategy to convert an FDA-approved anticancer drug, Pemetrexed (Pem), to a molecular hydrogelator with inherent chemical exchange saturation transfer (CEST) MRI signals.  ...[more]

Similar Datasets

| S-EPMC5485419 | biostudies-literature
| S-EPMC7167323 | biostudies-literature
| S-EPMC4025575 | biostudies-literature
| S-EPMC7053506 | biostudies-literature
| S-EPMC5870481 | biostudies-literature
| S-EPMC5137737 | biostudies-literature
| S-EPMC5704008 | biostudies-literature
| S-EPMC3837373 | biostudies-other
| S-EPMC8792502 | biostudies-literature
| S-EPMC5536232 | biostudies-literature